Todd Inman - Oct 3, 2022 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role: Chief Technology Officer
Signature: /s/ Marion Odence-Ford, by Power of Attorney
Stock symbol: OPRX
Transactions as of: Oct 3, 2022
Transactions value $: $0
Form type: 4
Date filed: 10/5/2022, 01:13 PM
Previous filing: Mar 3, 2022
Next filing: Mar 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OPRX	Restricted Stock Units	Award	$0	+9.97K		$0.00	9.97K	Oct 3, 2022	Common Stock	9.97K		Direct	F1, F2
transaction	OPRX	Stock Option	Award	$0	+19.5K		$0.00	19.5K	Oct 3, 2022	Common Stock	19.5K	$15.04	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
F2	The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.
F3	The stock option vests in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.